Carmat SA (EPA:ALCAR)
France · Delayed Price · Currency is EUR 0.4700
-0.0050 (-1.05%)
Aug 13, 2025, 5:35 PM CET
Carmat Company Description
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally.
Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure.
The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Carmat SA
| Country | France |
| Founded | 2008 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 153 |
| CEO | Stephane Piat |
Contact Details
Address: 36, avenue de l'Europe Vélizy-Villacoublay, 78140 France | |
| Phone | 33 1 39 45 64 50 |
| Website | carmatsa.com |
Stock Details
| Ticker Symbol | ALCAR |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0010907956 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Stephane Piat | Chief Executive Officer and Director |
| Pascale d'Arbonneau | Deputy GM, Administrative Director, Chief Financial Officer and Head of investor relations |
| Raouia Bouyanzer | Human Resources Director |
| Pr Christian Latremouille | Chief Medical Officer |